AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
291.31
+3.07 (1.07%)
At close: Nov 6, 2026, 4:00 PM EST
291.00
-0.31 (-0.11%)
After-hours: Nov 6, 2026, 7:58 PM EST

AbbVie Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
10,3424,2264,2784,86311,83611,542
Depreciation & Amortization
7,6678,1398,3868,6988,4678,521
Loss (Gain) From Sale of Assets
-----172-68
Asset Writedown & Restructuring Costs
2,5165,8637,2335,0071,4671,174
Stock-Based Compensation
927955911747671692
Other Operating Activities
2,0542,2097807112,7682,147
Change in Accounts Receivable
-808-1,49020766-1,455-1,321
Change in Inventory
-500-234-319-417-686-142
Change in Accounts Payable
-79511773,8401,7691,719
Change in Other Net Operating Assets
-745-827361-188-264-197
Operating Cash Flow
20,08919,03018,80622,83924,94322,777
Operating Cash Flow Growth
-3.70%1.19%-17.66%-8.43%9.51%29.50%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,217-1,214-974-777-695-787
Cash Acquisitions
-13,111-5,441-20,517-1,223-794-1,902
Investment in Securities
4141482-2292-21
Other Investing Activities
838-2918913774366
Investing Cash Flow
-13,449-6,643-20,820-2,009-623-2,344

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-5,2975,008---
Long-Term Debt Issued
-3,99416,963-2,0001,000
Total Debt Issued
17,4749,29121,971-2,0001,000
Short-Term Debt Repaid
--2,798-5,008---
Long-Term Debt Repaid
--6,797-9,613-4,149-14,433-9,414
Total Debt Repaid
-5,298-9,595-14,621-4,149-14,433-9,414
Net Debt Issued (Repaid)
12,176-3047,350-4,149-12,433-8,414
Issuance of Common Stock
172172214180262244
Repurchase of Common Stock
-1,506-980-1,708-1,972-1,487-934
Common Dividends Paid
-12,138-11,657-11,025-10,539-10,043-9,261
Other Financing Activities
-18545-42-742-1,102-674
Financing Cash Flow
-1,481-12,724-5,211-17,222-24,803-19,039

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1442-655-62-97
Net Cash Flow
5,145-295-7,2903,613-5451,297

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
18,87217,81617,83222,06224,24821,990
Free Cash Flow Growth
-4.13%-0.09%-19.17%-9.01%10.27%30.97%
Free Cash Flow Margin
28.59%29.13%31.65%40.62%41.77%39.13%
Free Cash Flow Per Share
10.6410.0510.0612.4413.6412.38
Levered Free Cash Flow
17,69318,33819,40922,97521,26119,394
Unlevered Free Cash Flow
19,55520,14621,16424,36522,65520,908

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3,0023,0022,8112,4692,5462,712
Cash Income Tax Paid
3,6263,6264,1004,7002,9883,648
Change in Working Capital
-3,417-2,362-2,7822,813-94-1,231
SEC Filings: 10-K · 10-Q